Literature DB >> 10496873

Limited interleukin-18 response in Salmonella-infected murine macrophages and in Salmonella-infected mice.

A Elhofy1, K L Bost.   

Abstract

Optimal immune responses against an intracellular bacterial pathogen, such as Salmonella, involve the production of gamma interferon (IFN-gamma), which activates macrophages. It has recently been suggested that, interleukin-18 (IL-18), in addition to IL-12, contributes to the induction of IFN-gamma following infection. Given this hypothesis, an optimal host immune response against intracellular bacterial pathogens would include the induction of IL-18 secretion by macrophages due to Salmonella infection. We questioned whether Salmonella could induce macrophages to upregulate their expression of IL-18 mRNA and secretion of IL-18. With cultures of murine macrophages, we were surprised to find that infection by wild-type Salmonella dublin resulted in decreased expression of IL-18 mRNA and IL-18 secretion rather than an increase. Reduction of macrophage-derived IL-18 expression by wild-type Salmonella occurred early in the response, suggesting a direct effect. Furthermore, mice orally inoculated with wild-type Salmonella were shown to have reduced IL-18 mRNA expression at mucosal sites within hours postinoculation. Together these studies demonstrate Salmonella-induced reductions in IL-18 expression, suggesting that this intracellular pathogen may be capable of limiting a potentially protective immune response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10496873      PMCID: PMC96848          DOI: 10.1128/IAI.67.10.5021-5026.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Regulation of human IL-18 mRNA expression.

Authors:  J D Marshall; M Aste-Amézaga; S S Chehimi; M Murphy; H Olsen; G Trinchieri
Journal:  Clin Immunol       Date:  1999-01       Impact factor: 3.969

2.  Anti-peptide antibodies recognize anti-substance P antibodies in an idiotypic fashion.

Authors:  D W Pascual; K L Bost
Journal:  Pept Res       Date:  1989 May-Jun

3.  The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

Authors:  L C Afonso; T M Scharton; L Q Vieira; M Wysocka; G Trinchieri; P Scott
Journal:  Science       Date:  1994-01-14       Impact factor: 47.728

4.  Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells.

Authors:  A J Puren; G Fantuzzi; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  Induction of interferon-gamma production in Th1 CD4+ T cells: evidence for two distinct pathways for promoter activation.

Authors:  J Yang; T L Murphy; W Ouyang; K M Murphy
Journal:  Eur J Immunol       Date:  1999-02       Impact factor: 5.532

6.  Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells.

Authors:  M Miettinen; S Matikainen; J Vuopio-Varkila; J Pirhonen; K Varkila; M Kurimoto; I Julkunen
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

7.  Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages.

Authors:  L Ramarathinam; D W Niesel; G R Klimpel
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

8.  Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium.

Authors:  P Mastroeni; S Clare; S Khan; J A Harrison; C E Hormaeche; H Okamura; M Kurimoto; G Dougan
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

9.  Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.

Authors:  J P Sypek; C L Chung; S E Mayor; J M Subramanyam; S J Goldman; D S Sieburth; S F Wolf; R G Schaub
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

10.  Recombinant interleukin 12 cures mice infected with Leishmania major.

Authors:  F P Heinzel; D S Schoenhaut; R M Rerko; L E Rosser; M K Gately
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more
  6 in total

1.  Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation.

Authors:  Mahmoud Rouabhia; Geneviève Ross; Nathalie Pagé; Jamila Chakir
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  A potential role for interleukin-18 in inhibition of the development of Cryptosporidium parvum.

Authors:  V McDonald; R C G Pollok; W Dhaliwal; S Naik; M J G Farthing; M Bajaj-Elliott
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

3.  Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii.

Authors:  G Cai; R Kastelein; C A Hunter
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

4.  Caspase-1-mediated activation of interleukin-1beta (IL-1beta) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection.

Authors:  Bärbel Raupach; Soo-Kyung Peuschel; Denise M Monack; Arturo Zychlinsky
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

5.  Th1 and Th1-inducing cytokines in Salmonella infection.

Authors:  Y Mizuno; H Takada; A Nomura; C-H Jin; H Hattori; K Ihara; T Aoki; K Eguchi; T Hara
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

6.  [Not Available].

Authors:  C C Bowman; K L Bost
Journal:  Open Microbiol J       Date:  2009-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.